The Costs of Alzheimer's Disease Treatment: the Rationale of Acetylcholinesterase Inhibitors Use?
From: I Kliniki Psychiatrycznej AM w Lodzi.
Psychiatria polska
- Publish Date:
- ISSN: 0033-2674
- Volume: 33
- Issue: 5
- Pages: 761-7
- Medium: Print
- Language:
- Citation (JAMA): Sobów T M, Kłoszewska I, et al. The Costs of Alzheimer's Disease Treatment: the Rationale of Acetylcholinesterase Inhibitors Use?. Psychiatr. Pol. ;33:761-7
Abstract
The costs of Alzheimer’s disease treatment in the era of acetylcholinesterase inhibitors use are critically discussed.
Mesh Headings (Keywords): Alzheimer Disease, Cholinesterase Inhibitors, Cost-Benefit Analysis, Health Expenditures, Humans, Poland
Check for Full Text / PubMed Unique Identifier (PMID): 10761441
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.